Zacks Investment Research Lowers Metlife (NYSE:MET) to Hold – PressOracle
Its strong international operations and disciplined capital management should drive long-term growth. However, the company’s exposure to catastrophe losses and investment in efficiency programs will put pressure on margins.”. Morgan Stanley decreased their price target on shares of Metlife from $53.00 to $52.00 and set an equal weight rating for the company in a research report on Wednesday, July 11th. The firm has a market capitalization of $46.48 billion, a P/E ratio of 9.61, a P/E/G ratio of 0.71 and a beta of 1.23. In other Metlife news, Chairman Steven A. Kandarian sold 85,683 shares of Metlife stock in a transaction on Tuesday, August 21st.